That is 20 years from when the invention occurs, and like you said sometimes you are only left with a few years to try and recoup the investment.
90 percent of the prescriptions that are written and filled in the United States, roughly, are for generic drugs.
The U.S. Congress shall have power to promote the progress of science and useful arts by securing, for limited times, to...
If companies couldn't recover their cost? That should be a fairly simple question to answer.
It feels like to me, just in closing, we need some kind of truth in pricing here.
This is according to the CBO, and they confirmed that there would be a loss of cures available on the market.
H.R. 3 really would completely gut the pharmaceutical innovations which we all so desperately need and we rely upon.
We don't need to have cures that could potentially come in the market not coming to the market.
Biopharmaceutical companies are far outspending the Federal Government for R&D for cures for various diseases.
Democrats have chosen to discard months of bipartisan work and conduct this partisan hearing to attack companies that ar...
The Congressional Budget Office said that it would result in 38 fewer cures over the next 20 years.